Variables |
N = 3,050 |
% |
Age group at diagnosis, years
< 20
20 – 29
30 – 39
40 – 49
50 – 59
≥ 60
Missing |
117
716
1060
801
288
65
3 |
3.8
23.6
34.8
26.3
9.4
2.1
0.0 |
Diagnosis facility1
Public
Private
Federal
Unknown |
757
2157
14
122 |
24.8
70.7
0.5
4.0 |
Exposure category2
Heterosexual contact only
IDU only
IDU and heterosexual contact
Other
Risk not identified |
467
388
430
13
752 |
48.1
12.7
14.1
0.4
24.7 |
Insurance3
Medicaid
Private
No coverage
Other
Clinical trials/Government
Unknown
Missing
DC ward4 of residence at diagnosis
1
2
3
4
5
6
7
8 |
977
507
204
412
74
329
547
316
150
14
316
504
412
619
719 |
32.0
16.6
6.7
13.5
2.4
10.8
17.9
10.4
4.9
0.5
10.4
15.5
13.5
20.3
23.6 |
Concurrent diagnosis of HIV/AIDS5
Yes
No |
309
716 |
10.1
23.5 |
Missing |
2025 |
66.4 |
Most recent CD4 count6 (cells/µl)
<200
≥200
Missing |
1109
1620
321 |
36.4
53.1
10.5 |
Most recent viral load7 (copies/ml)
≤400
>400
Missing |
474
991
1585 |
15.5
32.5
52.0 |
Disease progression8
Progressors
Non-progressors
Missing |
1814
1107
129 |
59.4
36.2
4.2 |
Treatment and referral services |
|
|
Has this patient been informed of HIV infection? |
|
|
Yes |
2746 |
90.0 |
No |
111 |
3.6 |
Missing |
193 |
6.4 |
This patient is receiving or has been referred for: |
|
|
HIV related medical services
Yes
No
Missing |
2310
614
126 |
75.7
20.1
4.1 |
Substance abuse treatment services
Yes
No
Missing |
532
2146
372 |
17.4
70.4
12.2 |
This patient received or is receiving: |
|
|
Anti-retroviral drugs
Yes
No
Missing |
1822
738
490 |
59.7
24.2
16.1 |
PCP prophylaxis
Yes
No
Missing |
996
1519
535 |
32.7
49.8
17.5 |